RecruitingNot ApplicableNCT06407102

Collection of Primary Human

Collection of Primary Human Nasal Epithelial Cells


Sponsor

University Hospital, Tours

Enrollment

100 participants

Start Date

Dec 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Treatment and prevention of respiratory infections are of great interest in many medical areas. Create a physical device covered by primary human nasal cells could be very usefull in order to analyse delivery and efficiency of drugs. In this context the aim of this project is to create a collection of primary cells from the human nasal epithelium. This collection will be realised during programmed surgery, thanks to a specific device dedicated to collect nasal cells. Then the cells will be sent to the lab in order to grow at the air-liquid interface, which is an excellent 'ex vivo' model for their study.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria4

  • Adult patients (age > 18 years) whose native language is French, or who understands French.
  • Affiliation with a French social security system (CMU accepted).
  • Informed consent, written and signed by the participant.
  • Planned rhinological surgery (meatotomy, septoplasty or turbinoplasty for example, but other surgeries as well)

Exclusion Criteria3

  • Patients under court protection, guardianship or curatorship.
  • Pregnant or breast-feeding women (positive pregnancy test for women of childbearing age).
  • Patients presenting a major alteration of the mucosa or a malignant rhinosinus pathology.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCollection of nasal cells during programme surgery

During programmed surgery (meatotomy, septoplasty or turbinoplasty for example, or other programmed surgeries), the surgeon will take an atraumatic sample from the nasal cavity using a dedicated device (brush) from the healthy nasal mucosa.


Locations(1)

AUSSEDAT

Tours, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06407102


Related Trials